Loading company…
Cologne-based drug developer focused on innovative medicines for indications with insufficient treatment options.
Nexigen GmbH develops innovative drugs for indications that have insufficient treatment options. Based in Cologne, Germany, it is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in